Biotechnology company devoted to research of restoring human health.
UNITY Biotechnology is developing therapeutics to extend healthspan by
slowing, halting or reversing diseases of aging. UNITY's initial focus
is on creating senolytic medicines to selectively eliminate senescent
cells and thereby treat age-related diseases, such as osteoarthritis,
eye diseases and pulmonary diseases.
Visit website: https://unitybiotechnology.com/
People at UNITY Biotechnology
Chief Medical Officer at Unity Biotechnology.
Chairman and CEO of UNITY Biotechnology.
Co-Founder and President, Unity Biotechnology
Co-Founder and President at Unity Biotechnology.
Chief Executive Officer at UNITY Biotechnology.
UNITY Biotechnology News
Unity Biotechnology launches clinical trial of a new senolytic
Lifespan.io - 13-Oct-2020
A new approach to treat diabetic macular oedemaRead more...
Labiotech gathers feedback from European biotechs on Unity failure
Labiotech - 28-Aug-2020
General feeling that failures are bound to happen - but that their approaches can succeedRead more...
Reason examines the failure of Unity Biotechnology's phase 2 senolytics trial
Fight Aging! - 18-Aug-2020
Disappointing first result - but lessons learnt and plenty of other strategies availableRead more...
Research into klotho is at a very interesting point
Fight Aging! - 03-Jun-2019
Research community is littered with interesting, promising foundations for therapies to treat agingRead more...
UNITY Biotechnology expands trial of osteoarthritis senolytic
UNITY Biotechnology - 22-Jan-2019
Initial results must be promising to enrol more patients at highest dosageRead more...
UNITY Biotechnologies Selects a New Senolytic Candidate
Life Extension Advocacy Foundation (LEAF) - 14-Jan-2019
Very early days but good to have more senolytics in the pipelineRead more...